Sanofi India Share Price

Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.As of 25 May 2026, Sanofi India share price is ₹3,181.90. The stock opened at ₹3,180.00, compared to its previous close of ₹3,163.20. During today's trading session, Sanofi India share price moved in the range of ₹3,151.60 to ₹3,199.50, with an average price of ₹3,175.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,151.60 and a high of ₹3,199.50. On the performance front, Sanofi India share price has declined by 29.91% over the last six months and is down 49.51% on a year-on-year basis.

The market capitalization of Sanofi India is ₹8,112 Crs, with a P/E ratio of 34.1 and a dividend yield of 2.87%.